Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
暂无分享,去创建一个
K. Horiuchi | Y. Okada | K. Fukuda | M. Shimoda | T. Nagai | T. Yoshikawa | T. Anzai | R. Yozu | T. Kohno | Yuichiro Maekawa | Toshiyuki Takahashi | Atsushi Anzai | H. Shimizu | H. Kaneko | A. Sasaki
[1] J. Arribas,et al. ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin , 2011, Oncogene.
[2] J. Arribas,et al. Cancer degradomics: ADAM17 regulates TGF-beta signaling through the cleavage of vasorin , 2010 .
[3] K. Horiuchi,et al. Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes , 2010, Circulation research.
[4] L. Rénia,et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. , 2010, The Journal of clinical investigation.
[5] M. McConnell,et al. Analysis of In Situ and Ex Vivo Vascular Endothelial Growth Factor Receptor Expression During Experimental Aortic Aneurysm Progression , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[6] G. Lopaschuk,et al. Tumor Necrosis Factor- –Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis , 2009 .
[7] J. Mactaggart,et al. Blocking TNF-α Attenuates Aneurysm Formation in a Murine Model1 , 2009, The Journal of Immunology.
[8] J. Arribas,et al. ADAM17 as a therapeutic target in multiple diseases. , 2009, Current pharmaceutical design.
[9] A. Ludwig,et al. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. , 2009, Seminars in cell & developmental biology.
[10] K. Horiuchi,et al. Cutting Edge: TNF-α-Converting Enzyme (TACE/ADAM17) Inactivation in Mouse Myeloid Cells Prevents Lethality from Endotoxin Shock1 , 2007, The Journal of Immunology.
[11] I. Evans,et al. Vascular Endothelial Growth Factor Synergistically Enhances Induction of E-Selectin by Tumor Necrosis Factor-α , 2007 .
[12] R. Ricci,et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.
[13] M M Thompson,et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[14] T. Masuda,et al. Expression and localization of tumour necrosis factor-α and its converting enzyme in human abdominal aortic aneurysm , 2004 .
[15] J. Bernhagen,et al. Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice , 2004, Circulation.
[16] C. Liapis,et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms , 2004, Current medical research and opinion.
[17] H. Schumacher,et al. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. , 2003, Journal of vascular surgery.
[18] David C. Lee,et al. Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.
[19] C. Peschle,et al. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. , 2003, Blood.
[20] Timothy C Greiner,et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.
[21] P. Thomas. Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma , 2001 .
[22] J. Lancaster,et al. Reactive oxygen species mediate tumor necrosis factor alpha‐converting, enzyme‐dependent ectodomain shedding induced by phorbol myristate acetate , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] N. Holbrook,et al. Oxidants, oxidative stress and the biology of ageing , 2000, Nature.
[24] A. Hingorani,et al. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model. , 1998, Journal of vascular surgery.
[25] R. Sayers,et al. Angiogenesis in abdominal aortic aneurysms. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[26] M Aguet,et al. Inducible gene targeting in mice , 1995, Science.
[27] Melinda Fitzgerald,et al. Immunol. Cell Biol. , 1995 .
[28] K. Newman,et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. , 1994, Circulation.
[29] A. Fukamizu,et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. , 1993, The Journal of biological chemistry.